METHYL 4-FLUORO-1H-INDAZOLE-5-CARBOXYLATE, 95.0%, 250mg

4-Bromo-5,6,7,8-tetrahydronaphthalen-1-amine hydrochloride, 97%, 10g

4-Fluoro-N-piperidin-4-ylmethyl-benzenesulfonamide hydrochloride, 95.0%, 100mg

4-Chlorphenol, >=98 %, zur Synthese, 250 g, Glasverpackung

(2R,3R)-3-Hydroxypyrrolidine-2-carboxylic acid, 95.0%, 500mg

(2S)-3-methyl-2-(N-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)butanoic acid, 97%, 500g

3-Bromo-5-hydroxybenzaldehyde, 98.0%, 25g

5-Isopropylthiazol-2-amine, 95.0%, 250mg

2-(Azetidin-3-yl)pyridine dihydrochloride, 95.0%, 250mg

Ro 48-8071 fumarate, 98%, 50mg

Banoxantrone dihydrochloride, 99.07%, 5mg

[RuCl(p-cymene)((S)-xylbinap)]Cl200mg

Fmoc-D-Asp-OAll, 95.0%, 25g